| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/27/2006 | US20060167057 Compounds for the treatment of CNS and amyloid associated diseases |
| 07/27/2006 | US20060167056 Polymorphs of {5-[3-(4,6-Difluoro-1H-benzoimidazol-2-yl)-1H-indazol-5-yl)-4-methyl-pyridin-3-ylmethyl}-ethyl-amine |
| 07/27/2006 | US20060167055 Non-nucleoside reverse transcriptase inhibitors |
| 07/27/2006 | US20060167054 Tumor necrosis factor (TNF alpha) inhibitors for treatinginflammatory/infectious/autoimmune/proliferative diseases; anticancer/tumor/diabetic/arthritic agents |
| 07/27/2006 | US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 07/27/2006 | US20060167052 Piperidine derivative, process for producing the same, and use |
| 07/27/2006 | US20060167051 Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride |
| 07/27/2006 | US20060167050 Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder |
| 07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
| 07/27/2006 | US20060167048 N-4-piperidinyl compounds as ccr5 modulators |
| 07/27/2006 | US20060167047 Tetrahydorquinoline derivatives and their use as fsh receptor modulators |
| 07/27/2006 | US20060167046 Histamine h3 receptor antagonists, preparation and therapeutic uses |
| 07/27/2006 | US20060167045 Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist |
| 07/27/2006 | US20060167044 Piperidine derivatives and their use as anti-inflammatory agents |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167042 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; alkylation |
| 07/27/2006 | US20060167041 Imidazopyridine compound |
| 07/27/2006 | US20060167040 useful as p38 kinase inhibitors |
| 07/27/2006 | US20060167039 Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 07/27/2006 | US20060167038 2E)-3-{3-cyano-4,6-dimethyl-1-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1H-pyrrolo[2,3-b]pyridin-2-yl}-N-(3,4-dimethoxyphenyl)prop-2-enamide; preventive, therapeutic agent and analgesic for overactive bladder |
| 07/27/2006 | US20060167037 Combinational radiotherapy and chemotherapy compositions and methods |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060167035 Quinoline derivative, its use, production and pharmaceutical agents containing the latter |
| 07/27/2006 | US20060167034 Novel benzonaphthyridines |
| 07/27/2006 | US20060167033 viral infections; lung tumor and gastric cancer; 7-2-(2-aminophenyldithio)phenyliminomethylcamptothecin |
| 07/27/2006 | US20060167032 Pharmaceutical composition and method for treating disorders of the central nervous system |
| 07/27/2006 | US20060167031 Method of administrating an anticancer drug containing alpha, alpha, alpha-trifluorothymidine and thymidine phosphorylase inhibitor |
| 07/27/2006 | US20060167030 Sulfonamido-macrocycles and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof |
| 07/27/2006 | US20060167029 pyridine or pyrimidine thieno(2,3-e)pyrimidine tricyclic compounds; metabotropic glutamate receptor antagonist; analgesic, anxiolytic agent: pain, migraine, urinary incontinence; neurodegenerative diseases: Alzheimer's disease |
| 07/27/2006 | US20060167028 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/27/2006 | US20060167027 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 07/27/2006 | US20060167026 Antipsychotic molecular-targeting epithelial growth factor receptor |
| 07/27/2006 | US20060167025 Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs |
| 07/27/2006 | US20060167024 Cancer combination therapy comprising azd2171 and zd1839 |
| 07/27/2006 | US20060167023 Substituted phenyl methanones |
| 07/27/2006 | US20060167022 Method of female sexual enhancement |
| 07/27/2006 | US20060167021 Inhibition of src for treatment of reperfusion injury related to revascularization |
| 07/27/2006 | US20060167020 Pyrazolopyrimidines as kinase inhibitors |
| 07/27/2006 | US20060167016 drugs which stimulate guanylate cyclase such as 1-(2-Fluorobenzyl)-3-{5-[(1S,5R)-1,3,3-trimethyl-6-azabicyclo[3.2.1]oct-6-yl]-2-pyrimidinyl}-1H-pyrazol[3,4-b]pyridine, used for prophylaxis of nervous system disorders |
| 07/27/2006 | US20060167015 Inhibitors of tyrosine kinases |
| 07/27/2006 | US20060167014 Piperazine compounds and medicinal use thereof |
| 07/27/2006 | US20060167013 5-methyl-2-(1-piperazinyl)benzenesulfonic acid; sodium channel blocking agent; cardiovascular disorder : ischemic heart disease, reperfusion, heart failure, hypertension, angina pectoris, arrhythmia, postsurgery complications |
| 07/27/2006 | US20060167012 Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| 07/27/2006 | US20060167011 Inhibitors of phosphorylation of platelet derived growth factor receptor |
| 07/27/2006 | US20060167010 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
| 07/27/2006 | US20060167009 Monocyclic substituted phenyl methanones |
| 07/27/2006 | US20060167008 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 07/27/2006 | US20060167006 Of pancreatic cancer, with imatinib or the mesylate salt thereof |
| 07/27/2006 | US20060167005 New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno [2,3-d] pyrimidine |
| 07/27/2006 | US20060167004 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 07/27/2006 | US20060167003 Probucol derivatives |
| 07/27/2006 | US20060167002 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060167000 veterinary medicine; neurodegenerative diseases; Alzheimers's Disease |
| 07/27/2006 | US20060166999 Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL) |
| 07/27/2006 | US20060166998 Pyrrolo[1,2-B]pyridazine compounds and their uses |
| 07/27/2006 | US20060166997 Useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein; 2-(1-aminoisoquinolin-6-ylamino)-2-(3-ethoxy-4-isopropoxyphenyl)-l -(2-phenylpyrrolidin-1-yl)ethanone, for example |
| 07/27/2006 | US20060166996 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 07/27/2006 | US20060166995 Piperidine-n-oxide-derivatives |
| 07/27/2006 | US20060166994 Method for treating renal failure |
| 07/27/2006 | US20060166993 Substituted at the 2 position with an aminophenyl group, e.g., 4-[5,7-Dimethyl-4-(3,4,5-trimethoxyphenoxy)imidazo[5,1-f][1,2,4]triazin-2-yl]-aniline; prophylaxis and treatment of cancer, neurodegenerative disorders such as Parkinson's disease, and psychiatric disorders such as schizophrenia. |
| 07/27/2006 | US20060166992 Heterocyclically substituted imidazotriazines |
| 07/27/2006 | US20060166991 Pyridine carboxamide derivatives and their use as pesticides |
| 07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
| 07/27/2006 | US20060166989 2-naphthamide derivatives |
| 07/27/2006 | US20060166988 Novel compounds |
| 07/27/2006 | US20060166987 Therapy for obesity; using secondary amino compound |
| 07/27/2006 | US20060166986 Novel stereoselective synthesis of benzimidazole sulfoxides |
| 07/27/2006 | US20060166985 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/27/2006 | US20060166983 Indole derivatives as ppar modulators |
| 07/27/2006 | US20060166982 Isotopically labelly indlinone derivatives and process for their preparation |
| 07/27/2006 | US20060166981 Novel compounds for use in weight loss and appetite suppression in humans |
| 07/27/2006 | US20060166980 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 07/27/2006 | US20060166979 for prophylaxis and treatment of atrial and ventricular arrhythmias |
| 07/27/2006 | US20060166978 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 07/27/2006 | US20060166977 Antibacterial agents |
| 07/27/2006 | US20060166976 Compositions and methods for treating or preventing convulsions or seizures |
| 07/27/2006 | US20060166975 Compositions and methods relating to novel compounds and targets thereof |
| 07/27/2006 | US20060166974 Azabenzoxazoles for the treatment of CNS disorders |
| 07/27/2006 | US20060166973 4-(7-Cyclopropylmethyl-6-oxo-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazin-5-yl)-benzonitrile; cytochrome P450 inhibitors; hypokalemia, hypertension, congestive heart failure, renal failure, restenosis, atherosclerosis, syndrome X, obesity, nephropathy, post myocardial infarction, coronary heart disease |
| 07/27/2006 | US20060166972 Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |
| 07/27/2006 | US20060166971 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 07/27/2006 | US20060166970 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 07/27/2006 | US20060166969 AMPA antagonists for the treatment of dizziness, including vertigo and Meniere's disorder |
| 07/27/2006 | US20060166968 Crystalline form of oxcarbazepine |
| 07/27/2006 | US20060166967 Use of r-10-hydroxy-10,11-dihydro-carbamazepine in neuropathic pain |
| 07/27/2006 | US20060166966 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis |
| 07/27/2006 | US20060166965 Atypical antipsychotic agents having low affinity for the D2 receptor |
| 07/27/2006 | US20060166964 Indoles fused to a five- to twelve-membered ring that is in turn fused to a five- or six-membered aromatic ring;, e.g., 13-cyclohexyl-N-(cyclopropylsulfonyl)-3-methoxy-6-(4-morpholinylcarbonyl)-7H-indolo[2,1-a][2]benzazepine-10-carboxamide |
| 07/27/2006 | US20060166963 Processes for producing 4-aminoquinazolines |
| 07/27/2006 | US20060166962 2-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methyl}1-oxypiperazinyl)methyl]phenoxy}pyrimidine; insecticide, controlling tobacco budworm, wheat, corn, soybeans, potatoes, and cotton; for soil-borne insects, such as termites and white grubs |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166960 also informulation with an H1 receptor antagonist; inflammatory diseases, allergic conditions, obesity, metabolic syndrome and central nervous system disorders |
| 07/27/2006 | US20060166959 Pharmaceutical compositions based on azetidine derivatives |
| 07/27/2006 | US20060166958 Crystalline amoxicillin trihydrate powder |
| 07/27/2006 | US20060166957 Methods of treating obesity and related disorders using tellurium selenium compounds |
| 07/27/2006 | US20060166956 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 07/27/2006 | US20060166955 Production process for 16-dehydropregnenoneol and its analogs |
| 07/27/2006 | US20060166954 Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester |